Q4 | 2025 NAVIGATING DEALFLOW: EUROPEAN SOFTWARE QUARTERLY
March 19, 2026
After years of rising growth multiples, Europe’s software market is repricing. Our first Navigating Dealflow: European Software Quarterly brings a clear view of how this reset is changing M&A, where valuations are landing, and which segments are holding up.
CDMO platforms will be the central arena for MedTech M&A in 2026
February 19, 2026
The MedTech manufacturing landscape is entering a pivotal phase.
Navigating Global Pharma Policy
January 26, 2026
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.
Life Sciences JPMorgan Healthcare Conference 2026 Recap
January 13, 2026
Key themes from the JPMorgan Healthcare Conference highlight how capital discipline, execution rigor, and operating efficiency are reshaping Life Sciences in 2026.